LINCOLN PHARMACEUTICALS
Back to Cashflow Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹8.11 Cr | ₹7.67 Cr | ₹0.70 Cr | ₹-1.88 Cr | ₹-4.50 Cr |
What is the latest Net Cash Inflow / Outflow ratio of LINCOLN PHARMACEUTICALS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹8.11 Cr |
| Mar2025 | ₹7.67 Cr |
| Mar2024 | ₹0.70 Cr |
| Mar2023 | ₹-1.88 Cr |
| Mar2022 | ₹-4.50 Cr |
How is Net Cash Inflow / Outflow of LINCOLN PHARMACEUTICALS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹8.11 Cr | 5.80 | |
| Mar2025 | ₹7.67 Cr | 1,003.17 | |
| Mar2024 | ₹0.70 Cr | Positive | |
| Mar2023 | ₹-1.88 Cr | Negative | |
| Mar2022 | ₹-4.50 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,026.2 Cr | 0.2% | -9.8% | -4.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,963.0 Cr | 0.7% | -0.3% | 3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹269,451.0 Cr | 4% | 8.9% | 54.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,456.0 Cr | 3.6% | -0.5% | 28.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,664.0 Cr | 2.5% | 13.6% | 9.4% | Stock Analytics | |
| CIPLA | ₹113,246.0 Cr | 3.2% | 5% | -11.9% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | 0.2% |
-9.8% |
-4.9% |
| SENSEX | 7% |
9.6% |
-6.7% |
You may also like the below Video Courses